Table 1.
Characteristics & laboratory data of 24 patients (baseline & after treatment values)
| Patient’s no. | Indication |
Duration of treatment (days) |
Sex |
Age (years, months) |
Weight (kg) |
Height (cm) |
Bilirubin (mg/dl) [T > up to 1.0] |
Albumin (g/l) [3.5–5.5] |
Serum creatinine ( mg/dl) [0.6–1.4] |
ALT (GPT) (IU/L) [Up to 40] |
AST (GOT) (IU/L) [Up to 40] |
eGFR** (Schwartz Formula) (ml/min/1.73 m2) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B* | A# | B | A | B | A | B | A | B | A | B | A | |||||||||
| 1 | Pneumonia | 14 | F |
0 Y 9 M |
9.5 | 70 | 0.2 | 0.28 | 3.7 | 3.9 | 1.1 | 0.5 | 10 | 20 | 27 | 35 | 26.3 | 57.8 | ||
| 2 | Meningitis | 10 | F |
0 Y 2.5 M |
1.7 | 40 | 0.2 | 0.25 | 3.3 | 3.5 | 0.3 | 0.4 | 30 | 35 | 55 | 68 | 55.1 | 41.3 | ||
| 3 | Urinary Tract Infection | 5 | F |
3 Y 0 M |
17.5 | 94 | 0.1 | 0.3 | 0.87 | 0.87 | 0.3 | 0.1 | 8.4 | 15 | 31.8 | 40 | 129.4 | 388.2 | ||
| 4 | Peritonitis | 14 | M |
9 Y 0 M |
24 | 133.5 | 0.08 | 0.2 | 1.87 | 1.4 | 0.23 | 0.1 | 18.8 | 29 | 25.6 | 29 | 239.7 | 551.4 | ||
| 5 | Infective Endocarditis | 21 | M |
4 Y 0 M |
14 | 103 | 0.3 | 0.4 | 4.35 | 3.74 | 1.96 | 1.06 | 4.1 | 13.8 | 9.4 | 37 | 21.7 | 40.1 | ||
| 6 | Meningitis | 10 | M |
12 Y 0 M |
35 | 150 | 0.1 | 0.2 | 4.2 | 4.2 | 0.63 | 0.5 | 15 | 17 | 24 | 28 | 98.3 | 123.9 | ||
| 7 | Pneumonia | 14 | F |
1 Y 10 M |
11 | 76 | 0.2 | 0.27 | 4.5 | 4.5 | 0.38 | 0.36 | 14 | 16 | 20 | 22 | 82.6 | 87.2 | ||
| 8 | Meningitis | 10 | M |
0 Y 8 M |
9 | 70 | 0.1 | 0.2 | 4.1 | 4.1 | 0.5 | 0.42 | 15 | 20 | 50 | 60 | 57.8 | 68.8 | ||
| 9 | Meningitis | 14 | M |
0 Y 5 M |
7.5 | 66 | 0.1 | 0.23 | 4 | 4 | 0.53 | 0.5 | 19 | 23 | 40 | 49 | 51.4 | 54.5 | ||
| 10 | Pneumonia | 7 | F |
2 Y 2 M |
10.3 | 77 | 0.2 | 0.25 | 4.5 | 4.5 | 0.64 | 0.55 | 12 | 17 | 23 | 61 | 49.7 | 57.8 | ||
| 11 | Meningitis | 10 | F |
11 Y 0 M |
34 | 145 | 0.2 | 0.29 | 4.4 | 4.4 | 1 | 0.9 | 16 | 18 | 25 | 29 | 59.9 | 66.5 | ||
| 12 | Meningitis | 10 | F |
1 Y 4 M |
11.5 | 76 | 0.1 | 0.22 | 4.3 | 4.3 | 0.6 | 0.4 | 18 | 20 | 20 | 21 | 52.3 | 78.5 | ||
| 13 | Gastroenteritis | 7 | M |
1 Y 7 M |
11 | 75 | 0.4 | 0.9 | 4.32 | 4.26 | 0.21 | 0.21 | 48.8 | 55 | 59.9 | 65 | 147.5 | 147.5 | ||
| 14 | Meningitis, Gastroenteritis | 10 | M |
0 Y 5 M |
6.8 | 66 | 0.1 | 0.2 | 4 | 4.2 | 0.46 | 0.32 | 18 | 25 | 38 | 40 | 59.3 | 85.2 | ||
| 15 | Gastroenteritis | 7 | F |
0 Y 3 M |
6.6 | 60 | 0.2 | 0.25 | 4.5 | 4.4 | 0.36 | 0.3 | 45.1 | 50 | 74 | 77 | 68.8 | 82.6 | ||
| 16 | Meningitis | 10 | F |
11 Y 0 M |
15 | 154 | 0.2 | 0.27 | 4.35 | 4.3 | 0.64 | 0.5 | 51 | 54 | 75 | 79 | 99.4 | 127.2 | ||
| 17 | Meningitis | 7 | M |
0 Y 4 M |
5.5 | 65 | 0.1 | 0.19 | 4.55 | 4.5 | 0.4 | 0.30 | 25 | 30 | 36 | 40 | 67.1 | 89.5 | ||
| 18 | Urinary Tract Infection | 5 | F |
5 Y 0 M |
19 | 108 | 0.1 | 0.15 | 1.84 | 2 | 1.6 | 1.2 | 25 | 35 | 39 | 45 | 27.9 | 37.2 | ||
| 19 | Pneumonia | 14 | F |
0 Y 11 M |
12 | 73 | 0.2 | 0.27 | 3.7 | 3.9 | 0.6 | 0.5 | 15 | 20 | 29 | 35 | 50.2 | 60.3 | ||
| 20 | Meningitis | 10 | F |
1 Y 0 M |
13 | 78 | 0.28 | 0.35 | 3.2 | 3.3 | 0.5 | 0.4 | 39 | 45 | 49 | 69 | 64.4 | 80.5 | ||
| 21 | Pneumonia | 14 | F |
4 Y 0 M |
16 | 107 | 0.2 | 0.4 | 4 | 4.2 | 1.85 | 1.4 | 25 | 29 | 45 | 50 | 23.9 | 31.6 | ||
| 22 | Cystitis | 7 | M |
10 Y 0 M |
37 | 158 | 0.29 | 0.5 | 3 | 3.2 | 0.72 | 0.65 | 27 | 30 | 39 | 45 | 90.6 | 100.4 | ||
| 23 | Gastroenteritis | 7 | M |
0 Y 6 M |
8 | 66 | 0.2 | 0.4 | 3.8 | 3.7 | 0.35 | 0.3 | 42 | 46 | 53 | 69 | 77.9 | 90.9 | ||
| 24 | Pneumonia | 14 | M |
6 Y 5 M |
22 | 116 | 0.2 | 0.27 | 3.78 | 3.9 | 0.8 | 0.7 | 19 | 25 | 38 | 45 | 59.9 | 68.4 | ||
| Median | 10 | 1.705 | 11.75 | 76.5 | 0.2 | 0.27 | 4 | 4.05 | 0.565 | 0.46 | 18.9 | 25 | 38 | 45 | 59.9 | 79.5 | ||||
| Minimum | 5 | 0.21 | 1.7 | 40 | 0.08 | 0.15 | 0.87 | 0.87 | 0.21 | 0.1 | 4.1 | 13.8 | 9.4 | 21 | 21.7 | 31.6 | ||||
| Maximum | 21 | 12 | 37 | 158 | 0.4 | 0.9 | 4.55 | 4.5 | 1.96 | 1.4 | 51 | 55 | 75 | 79 | 239.7 | 551.4 | ||||
*B baseline value; #A is the value after treatment with ceftriaxone
** According to National Kidney Foundation (NKF), eGFR of 90 or higher is in the normal range, 60–89 may mean early kidney disease, 15–59 may indicate kidney disease and below 15 may mean kidney failure
ALT alanine aminotransferase, AST aspartate aminotransferase, eGFR estimated glomerular filtration rate. Y year, M month